Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
Recruiting · NCT04109755 · Registry updated 2021-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Phase 2 | 2021-09-30 | NCT04109755 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital, Geneva | 108 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hôpitaux Universitaires de Genève | Geneva | Switzerland | 17 |